APP and Alzheimer disease: Selectively removing the senescent OPCs alleviates the Aβ accumulation in the APP/PS1 mice (Zhang et al., 2019), and inhibiting mTOR signaling also reduces Aβ levels in another AD mice model (Spilman et al., 2010).